The DOI matches its Crossref record; 211 of the 215 references it cites were found in a registry or an index.
Regulation of Src Family Kinases during Colorectal Cancer Development and Its Clinical Implications
Open accessAbstract
Src family kinases (SFKs) are non-receptor kinases that play a critical role in the pathogenesis of colorectal cancer (CRC). The expression and activity of SFKs are upregulated in patients with CRC. Activation of SFKs promotes CRC cell proliferation, metastases to other organs and chemoresistance, as well as the formation of cancer stem cells (CSCs). The enhanced expression level of Src is associated with decreased survival in patients with CRC. Src-mediated regulation of CRC progression involves various membrane receptors, modulators, and suppressors, which regulate Src activation and its downstream targets through various mechanisms. This review provides an overview of the current understanding of the correlations between Src and CRC progression, with a special focus on cancer cell proliferation, invasion, metastasis and chemoresistance, and formation of CSCs. Additionally, this review discusses preclinical and clinical strategies to improve the therapeutic efficacy of drugs targeting Src for treating patients with CRC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In response signaling from a variety of RTKs (including EGFR, HER2, HER4, PDGFR, VEGFR, FGFR4, GPCR, C-MET, IL-4/IL13/IL-13Rα2, IL-6ST/IL-6R/IL-11R), SRC has been reported to mediate diverse cell signaling pathways including RAS/MAPK (proliferation), PI3K/AKT (survival), FAK (adhesion/migration/EMT), and STAT3 (angiogenesis) [17, 49, 50].”
From An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy (2022) · cites this paper as [50]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
Dongre, A., & Weinberg, R. A. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0080-4 · Cited by 3,876 · cited 1×
“This transition is closely associated with tumor malignancy and chemoresistance [120,121].”
BackgroundEMT, CSCs, and drug resistance: the mechanistic link and clinical implications
Shibue, T., & Weinberg, R. A. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.44 · Cited by 2,539 · cited 4×
“The cell surface glycoprotein, CD44, is one of the CSC-specific cell surface markers in various cancers, including CRC [121,173].”
BackgroundInfluentialThe role of MicroRNAs in human cancer
Peng, Y., & Croce, C. M. (2016) · Signal Transduction and Targeted Therapy · doi:10.1038/sigtrans.2015.4 · Cited by 2,483 · cited 1×
“MicroRNAs (miRNAs) are small non-coding RNAs that play an essential role in the regulation of biological processes during tumor progression [102].”
BackgroundYeatman, T. J. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1366 · Cited by 1,113 · cited 1×
“The purification of v-Src (pp60src) from Rous sarcoma virus (RSV), which activates the insulin receptor, led to the identification of various Src family kinases (SFKs) [1,2], such as Src, Fyn, Yes, Yrk, Fgr, Hck, Blk, lymphocyte-specific protein tyrosine kinase (Lck), and Lyn.”
BackgroundKinase inhibitors: the road ahead
Ferguson, F. M., & Gray, N. S. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.21 · Cited by 1,009
Pai, R., Soreghan, B., Szabo, I. L., Pavelka, M., Baatar, D., & Tarnawski, A. S. (2002) · Nature Medicine · doi:10.1038/nm0302-289 · Cited by 836 · cited 1×
“Prostaglandin E2 (PGE2), a bioactive lipid molecule produced by cyclooxygenase enzymes (COX-1 and COX-2), promotes the activation of EGFR through matrix metalloproteinase (MMP)-2 and MMP-9 activation, which results in the activation of Src/MAPK/ERK signaling pathway [36].”
Backgroundβ-Catenin-Driven Cancers Require a YAP1 Transcriptional Complex for Survival and Tumorigenesis
Rosenbluh, J., Nijhawan, D., Cox, A. G., Li, X., Neal, J. T., Schafer, E. J., Zack, T. I., Wang, X., Tsherniak, A., Schinzel, A. C., et al. (2012) · Cell · doi:10.1016/j.cell.2012.11.026 · Cited by 757
Src kinases as therapeutic targets for cancer
Kim, L. C., Song, L., & Haura, E. B. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.129 · Cited by 700 · cited 1×
“preclinical and clinical trials, using monotherapy or combination therapy with other neoplastic drugs, have revealed that the kinase inhibitors exert a synergistic effect for inhibiting tumor progression and prolonging the survival of patients with tumors, including CRC [3,207].”
BackgroundA Phosphatase Associated with Metastasis of Colorectal Cancer
Saha, S., Bardelli, A., Buckhaults, P., Velculescu, V. E., Rago, C., Croix, B. S., Romans, K. E., Choti, M. A., Lengauer, C., Kinzler, K. W., et al. (2001) · Science · doi:10.1126/science.1065817 · Cited by 648 · cited 1×
“CRC cells were reported to exhibit upregulated expression of PRL-3 when compared to non-metastatic CRC cells or normal colon epithelium [61].”
BackgroundClaudin-1 regulates cellular transformation and metastatic behavior in colon cancer
Dhawan, P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24543 · Cited by 566 · cited 1×
“CLDN1 activates Src and PI3K by forming the CLDN1/Src complex, which increases tumor growth and liver metastasis in vivo by promoting EMT [162,163].”
Background
Research works printed but not linked: 1
- Schoenherr, 2014, Eps8 controls Src- and FAK-dependent phenotypes in squamous carcinoma cells, J. Cell Sci., 127, 5303
Cited by
Poh, A. R., & Ernst, M. (2023) · Oncogene · doi:10.1038/s41388-023-02701-x · Cited by 60
Kharkar, P. S. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01336 · Cited by 47
Pathogenic nsSNPs that increase the risks of cancers among the Orang Asli and Malays
Khoruddin, N. A., Noorizhab, M. N. F., Teh, L. K., Yusof, F. Z. M., & Salleh, M. Z. (2021) · Scientific Reports · doi:10.1038/s41598-021-95618-y · Cited by 34
Src Family Tyrosine Kinases in Intestinal Homeostasis, Regeneration and Tumorigenesis
Sirvent, A., Mevizou, R., Naim, D., Lafitte, M., & Roche, S. (2020) · Cancers · doi:10.3390/cancers12082014 · Cited by 35
Zhang, W., Pan, R., Lu, M., Zhang, Q., Lin, Z., Qin, Y., Wang, Z., Gong, S., Lin, H., Chong, S., et al. (2021) · Oncogene · doi:10.1038/s41388-021-02029-4 · Cited by 31
Metadata
- Authors
- Jin, W.
- Affiliations
- Gachon University (KR)
- Corresponding author
- Jin, Wook
- ORCID
- Jin, Wook
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2020-05-23
- Volume
- 12
- Issue
- 5
- Pages
- 1339
- ISSN
- 2072-6694 (ISSN-L)
- PMC
- PMC7281431
- OpenAlex
- W3026270876
- Cited by
- 86
- References
- 215
- Citations by year
- 2026: 9 · 2025: 10 · 2024: 13 · 2023: 20 · 2022: 16 · 2021: 11 · 2020: 6
- FWCI
- 2.03
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Cancers (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Research Foundation of Korea (2020R1A2C1012484)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Mechanisms and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- Src family kinases, colorectal cancer, tumor progression, cell proliferation, metastasis, chemoresistance, cancer stem cells, Src kinase inhibitor, non-receptor tyrosine kinase, patient survival
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Regulation of Src Family Kinases during Colorectal Cancer Development and Its Clinical Implications. https://app.cochat.ai/papers/10.3390/cancers12051339
- The paper
- Jin, W. (2020). Regulation of Src Family Kinases during Colorectal Cancer Development and Its Clinical Implications. Cancers. https://doi.org/10.3390/cancers12051339
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.